Both in Pharmaceuticals
Innoviva vs Tyra Biosciences
Over the past year INVA returned +10.9% and TYRA returned +65.3%; their daily moves had a correlation of 0.10.
INVA +10.9% TYRA +65.3%Growth of $1, one year, split-adjusted
| Metric | INVA | TYRA |
|---|---|---|
| Price | $21.11 | $21.98 |
| Market cap | $1.53B | $1.51B |
| Today | −0.57% | +2.47% |
| 1 month | +0.7% | −11.9% |
| 6 months | −7.9% | −36.5% |
| Year to date | +5.6% | −16.4% |
| 1 year | +11.9% | +69.5% |
| Revenue growth (YoY) | +19.3% | — |
| Gross margin | 81.3% | — |
| Net margin | −69.8% | — |
| P/E (TTM) | 4.3× | — |
| Price / sales | 3.5× | — |
| Net cash | $319.0M | $353.9M |
| Dividend yield | — | — |
| Volatility (60d) | 22.1% | 87.6% |
| Short % of float | 10.3% | 29.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).